COVID-19: Vaccines and Therapeutics

May 14, 2021
In a study of more than 1,800 health care workers across 33 sites in 25 U.S. states, the Pfizer and Moderna COVID-19 vaccines reduced symptomatic COVID-19 infections by 94% in fully vaccinated workers and 82% in partially vaccinated workers, the Centers for Disease Control and Prevention reported. 
May 13, 2021
Adopting the advice of its Advisory Committee on Immunization Practices, the Centers for Disease Control and Prevention last night recommended the Pfizer-BioNTech vaccine for children aged 12 to 15, paving the way for providers to begin vaccinating them immediately.
May 13, 2021
When Cheryl Owens saw the growing skepticism about the COVID-19 vaccines among African Americans in the city of Tuskegee, Ala., where she was born and raised, she decided to get involved.
May 12, 2021
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended Pfizer’s COVID-19 vaccine for administration in adolescents ages 12 to 15.
May 11, 2021
The Federal Emergency Management Agency is reminding stakeholders that funding is available under FEMA’s Public Assistance program, including for community engagement and information dissemination to promote vaccination availability, scheduling, and accessibility, as well as reimbursement for…
May 10, 2021
The Food and Drug Administration announced the expansion of its emergency use authorization for Pfizer’s COVID-19 vaccine to include adolescents ages 12 to 15.
May 10, 2021
Illinois health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence in Illinois of the SARS-CoV-2 P.1 variant, which is not susceptible to the combination therapy, the Office of the Assistant Secretary for…